Covid-19 Incidence And Mortality By Age Strata And Comorbidities In Mexico City: A Focus In The Pediatric Population

CASTILLA PEON, M. F.; Gonzalez-Garcia, N.; Solorzano-Santos, F.; Jimenez Juarez, R.; Martinez Bustamante, M. E.; Minero Hibert, M. A.; Garduno Espinosa, J.

Introduction: SARS-COV2 appears less frequently and less severely in the pediatric population than in older age groups. In the face of the urgent need to reactivate activities suspended during the lockdown, mainly those essential for child development, this study aims to describe the risks of death of persons infected with SARS-COV2 by age group and according to the presence of comorbidities. Methodology: We analyzed data of confirmed SARS-COV2 infection cases where symptoms began between February 22th, 2020, and March 31, 2021, as published by the General Epidemiology Direction (DGE) of the Mexican Ministry of Health. We calculated COVID-19 incidence and mortality by age group with population data from the Statistics and Population National Institute (INEGI), estimating the correlation between risk of death and the presence of comorbidities. Results: Mortality in SARS-COV2 infected people varied considerably, between 7 to 155 deaths per million per year in the under-20 age groups compared to 441 to 15929 in the older age groups. Mortality in pediatric populations is strongly associated with comorbidities (OR: 4.6- 47.9) compared to the milder association for older age groups (OR: 3.16-1.23). Conclusions: The risk of death from SARS-COV2 infection in children is low and strongly associated with comorbidities.